United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2017_register
executive
2017-07-26
article
Branded Prescription Drug Fee
Rules and Regulations
D09002ee1bdbbd794
D09002ee1bdbbd843
United States
Department of the Treasury
originator
org
United States Government Agency or Subagency
United States
Internal Revenue Service
originator
org
United States Government Agency or Subagency
This document contains final regulations that define the term controlled group for purposes of the branded prescription drug fee. The final regulations supersede and adopt the text of temporary regulations that define the term controlled group. The final regulations affect persons engaged in the business of manufacturing or importing certain branded prescription drugs.
82 FR 34611
https://www.govinfo.gov/app/details/FR-2017-07-26/2017-15643
2017-15643
fr26jy17-2
RIN 1545-BM26
4830-01-P
TD 9823
https://www.govinfo.gov/app/details/FR-2017-07-26/2017-15643
https://www.govinfo.gov/content/pkg/FR-2017-07-26/html/2017-15643.htm
https://www.govinfo.gov/content/pkg/FR-2017-07-26/pdf/2017-15643.pdf
Drugs
Reporting and Recordkeeping Requirements
2 p.
34611
34612
82 FR 34611
Code of Federal Regulations
Title 26 Part 51
26 CFR Part 51
Regulation Identification Number 1545-BM26
RIN 1545-BM26
Branded Prescription Drug Fee; Federal Register Vol. 82, Issue
RULE
2017-15643
DEPARTMENT OF THE TREASURY
Internal Revenue Service
2017-07-24
TD 9823
4830-01-P
2017-15643
Final regulations and removal of temporary regulations.
This document contains final regulations that define the term controlled group for purposes of the branded prescription drug fee. The final regulations supersede and adopt the text of temporary regulations that define the term controlled group. The final regulations affect persons engaged in the business of manufacturing or importing certain branded prescription drugs.
Effective Date: The final regulations are effective July 24, 2017.
Rachel S. Smith at (202) 317-6855 (not a toll-free number).
Drugs
Reporting and Recordkeeping Requirements
Branded Prescription Drug Fee
,
Federal Register
Vol. 82, no. 142
Office of the Federal Register, National Archives and Records Administration
2017-07-26
continuing
daily
deposited
born digital
245 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2017-07-26
P0b002ee195b8cc90
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr26jy17
https://www.govinfo.gov/app/details/FR-2017-07-26
https://www.govinfo.gov/content/pkg/FR-2017-07-26/pdf/FR-2017-07-26.pdf
https://www.govinfo.gov/content/pkg/FR-2017-07-26/xml/FR-2017-07-26.xml
fdlp
34597
34789
DGPO
2017-07-26
2023-04-28
FR-2017-07-26
machine generated
eng
FR
FR-2017-07-26
82
142